3 Things In Biotech You Should Learn Today: September 6, 2017Seeking AlphaCellectis (CLLS) is developing a novel target for CAR-T cells, CD123, with the ultimate goal of treating acute myeloid leukemia (AML) and blastic plasmacytoid dendritic cell neop… Continue reading
Cancer Therapy AdvisorAdoptive Cellular Immunotherapy Improves Survival in Resected NSCLCCancer Therapy AdvisorAdjuvant adoptive cellular immunotherapy plus chemotherapy improved overall survival (OS) among patients with resected non-small-cell lung ca… Continue reading
Curetoday.comThe Future of Triple-Negative Breast Cancer Treatment Includes Immunotherapy CombinationsCuretoday.comSingle-agent immunotherapy has demonstrated a modest clinical response in pretreated patients. The findings of the phase 2 KEYNOTE-086 tr… Continue reading
Markets Insider |
Next-gen gene editor will be the CRISPR sequel we’ve been waiting for
Digital Trends Just when we were getting used to the CRISPR/Cas9 gene editing revolution, a new “fourth-generation” DNA base editor has come along — offering a new way to modify the genetic code that may be safer in terms of reducing potential mistakes. Base editing … University of South Carolina to provide Transomic Technologies’ CRISPR-Cas9 products through its Viral Vector CoreMarkets Insider How Gene Editing Might Reshape Diabetes TreatmentA Sweet Life |
Salon |
US clears gene therapy for childhood leukemia
Shanghai Daily (subscription) The Food and Drug Administration said the approval was historic, the first gene therapy to hit the US market. Made from scratch for every patient, it’s one of a wave of “living drugs” under development to fight additional blood cancers and other tumors … Pioneering cancer gene therapy gets green light — and $475,000 …Salon FDA approves ‘transformative’ type of gene therapyJordan Times FDA approves first gene therapy in the United StatesPharmacy Today, American Pharmacists Association, pharmacist.com SFGate –Gears Of Biz all 18 news articles » |
PR Web |
FDA Commissioner Announces Stem Cell Enforcement Shift, Plans to Develop Comprehensive Regenerative Medicine …
Lexology (registration) In a major public move that has been long-awaited by proponents of evidence-based stem cell science, FDA Commissioner Scott Gottlieb issued a lengthy statement on August 28, 2017 “on the FDA’s new policy steps and enforcement efforts to ensure proper … Stem Cell Assay Market – Industry Analysis, Size, Share, Growth, Trends, and Outlook to 2025Medgadget (blog) American Stem Cell Centers of Excellence Opens Clinic in Dallas, TXBaystreet.ca Robert Russell Named Director of Physician Engagement at Okyanos Center for Regenerative MedicinePR Web (press release) |
Phys.Org |
Curved substrates restrict spreading and induce differentiation of stem cells
Phys.Org Using Yang’s patented and patent-pending technology, stem cells were grown on microscopic glass balls immobilized in a gel medium. Unlike the well-spread stem cells grown on a two-dimensional surface, the stem cells on the glass balls were almost … |